Flibanserin, which aims to restore lost libido in women, has been twice rejected by the F.D.A., which cited limited effectiveness as well as side effects. The drug will go before agency advisers again on Thursday.
from NYT > Health http://ift.tt/1KwW8fs
via health&fitness
Aucun commentaire:
Enregistrer un commentaire